ANAB compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ANABAnaptysbio, Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ANABAnaptysbio, Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ANAB

1 of 4at or beyond implied

Reportimpliedrealized× implied

May 13 '26±6.7%▼−4.41%×0.66

Mar 4 '26±14.1%▲+14.61%×1.04

Jan 12 '26±10.0%▲+9.76%×0.98

Nov 5 '25±16.7%▲+3.63%×0.22

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 29 '26±5.1%▲+6.63%×1.29

Aug 5 '26±6.2%▲+4.86%×0.79

= impliedANAB realized, solidLLY realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

Apr 30 '26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ANABAnaptysbio, Inc

46.43▲+1.87%· post 46.43

Mkt cap$1.4BRevenue$26MQ1 FY26Revenue$235MFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

ClosedNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 6 '26

ANABAnaptysbio, Inc

LLYELI Lilly & Co

46.43▲+1.87%post 46.43

Price

1,360.90▼−0.28%post 1,358.90

$1.4B

Mkt cap

$1.2T

Q1 FY26$26M

Revenue

$24.4BQ3 FY26

FY25$235M

Revenue

$65.2BFY25

ANAB46.43▲+1.87%vsLLY1,360.90▼−0.28%ClosedNov 6 '26